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Abstract—The use of a bone-anchored device to transmit 
electrical signals from internalised muscle electrodes was studied 
in a sheep model. The bone-anchored device was used as a 
conduit for the passage of a wire connecting an internal epimysial 
electrode to an external signal-recording device. The bone-
anchored device was inserted into an intact tibia and the 
electrode attached to the adjacent M. peroneus tertius. 
‘Physiological’ signals with low signal to noise ratios were 
successfully obtained over a 12-week period by walking the sheep 
on a treadmill. Reliable transmission of multiple muscle signals 
across the skin barrier is essential for providing intuitive, 
biomimetic upper-limb prostheses. This technology has the 
potential to provide a better functional and reliable solution for 
upper-limb amputee rehabilitation: attachment and control. 
 
Index Terms— Prosthetic limbs, implantable myoelectrodes, 
bone-anchored device, myoelectric control. 
 
I. INTRODUCTION 
HERE are 94,000 estimated upper limb amputees in 
Europe [1] and a further 41,000 in the United States [2]. 
Upper limb loss results in significant physical and 
psychological morbidity with the majority of cases occurring 
due to trauma in young patients. 
Prostheses have remained the mainstay for significant upper 
limb loss rehabilitation, however they pose 2 main challenges; 
 
Manuscript received July 16th 2012. This work was supported in part by the 
Royal College of Surgeons of England Surgical Research Fellowship, 
Restoration of Appearance and Function Trust (RAFT), Rosetrees Trust, 
EPSRC. 
A preliminary version of this work was presented at the 57th Annual 
Meeting of the Plastic Surgery Research Council, Ann Arbor, Michigan, USA, 
June 2012. Asterisk indicates corresponding author. 
* Y Al-Ajam is with the Institute of Biomedical Engineering, University 
College London, Royal National Orthopaedic Hospital, Stanmore, HA7 4LP, 
UK. (phone: +44 208 909 5304; fax: +44 208 420 7392; e-mail: 
yazan.ajam@gmail.com).  
H. Lancashire, C. Pendegrass, R. P. Dowling, S. J. G. Taylor, and G. Blunn 
are with the Institute of Biomedical Engineering, UCL, RNOH, Stanmore 
HA7 4LP, UK (email: henry.lancashire.10@ucl.ac.uk; 
c.pendegrass@ucl.ac.uk; robert.p.dowling@gmail.com; 
stephen.taylor@ucl.ac.uk; g.blunn@ucl.ac.uk). 
N. Kang is with the Department of Plastic and Reconstructive Surgery, 




attachment of the prosthesis to the amputation stump and 
control of the end device. 
Current prostheses are usually controlled using muscle 
signals from skin-surface electrodes, typically two, placed on 
antagonist muscles. These signals can be used directly, to 
drive a single degree of freedom (DoF), or to control an event-
driven finite-state map, where modes are selected by a rarely 
used signal (e.g. co-contraction or double-contraction) [3]. 
  The inherent disadvantage of this system is that it is 
unintuitive, and because the prosthesis is controlled in a non-
physiological way, actions can only be performed in series, 
interposed by mode switching to change the DoF.  
In a human hand there are 22 DoF controlled by 38 muscles 
[4]. Upper limb prostheses require 38 actuators, each with a 
separate activating signal, to fully mirror hand motion. 
Therefore in order to improve hand control, an increase in the 
number of control channels is required. As the number of 
muscles adjacent to the humerus is limited, targeted muscle 
reinnervation (TMR) may provide a solution in above elbow 
amputees [5]. In this surgical technique peripheral nerves 
normally supplying the upper limb are rerouted to nerves 
innervating chest and torso muscles. Following nerve 
regeneration, patients are fitted with an array of surface 
electrodes to ‘map out' the muscle areas responsible for 
specific hand actions. Patients are able to exert intuitive 
control of prostheses without the need for mode switching. 
However, this technique is less applicable in patients with 
trans-radial amputations. Furthermore, reliance on surface 
electrodes has its limitations, namely difficulty with placing 
the electrodes in a repeatable location, electrode lift-off, 
impedance variability due to skin moisture, and signal 
contamination from cross-talk caused by interference from 
deep or adjacent muscles [4], [6].  
Although considerable advancements in improving intuitive 
control using pattern recognition have been made, reliability 
issues have precluded their use in commercial prostheses to 
date [7]. 
One solution to the problems associated with skin surface 
electrodes is placement of the electrodes directly on or in the 
muscle. This also allows targeting of individual muscles 
responsible for specific actions, increasing selectivity and 
reducing cross-talk. However, implantable electrodes pose a 
significant challenge with transcutaneous data transmission. 
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Early designs (and some current cortical designs) use hard-
wired connections, these are either too fragile or too bulky, 
and can provide a route for infection, negating the advantage 
of implantable electrodes [8]. 
Although signal telemetry can be used, this increases the 
complexity of designs and can limit the number of channels. A 
recent electromyography (EMG) telemetry system by Weir et 
al. [6] transmitted a maximum of 32 channels of data at 
approximately 470 samples per second, with a low-pass corner 
of <235 Hz, this is sufficient for gross muscle movements, but 
high frequency EMG signals and some motor unit action 
potential spikes will not be detected [9]. 
Current prostheses, using suction cups, sleeves, sockets or 
harnesses result in sweating, chaffing, numbness, discomfort, 
heterotopic ossification and potentially serious skin infections. 
This combined with the low levels of dexterity provided by 
prosthetic limbs lead to low satisfaction and high rates of 
prosthesis abandonment [10]. 
 For upper-limb amputees, osseointegration of a 
transcutaneous implant directly to the residual bone of the 
stump can provide a solution to the problems associated with 
prosthesis attachment and at the same time provide an 
engineered conduit for the hard wire coupling of electrodes 
and actuators. Clinical experience with an osseointegrated 
prosthesis for a proximal humeral amputee has shown this 
technique to be revolutionary [11]. Combining osseointegrated 
prostheses with a hard-wired connection will avoid the 
fragility of earlier hard-wired connections and the channel 
limitations of current telemetry devices. 
The combination of bio-signal recording and direct skeletal 
attachment was first reported by Pitkin [12]. In a single, acute, 
recording session it was shown that EMG signals could be 
recorded from a sedated rabbit amputation model using silver-
plated wire electrodes. 
The long-term reproducibility of signals with low noise 
from internal EMG electrodes is of considerable importance if 
this approach is to be used clinically. Our study aims to record 
EMG signals from a known muscle in an unsedated animal 
over a period of time and transfer these signals using a hard-
wired, bone-anchored prosthesis. 
  
II. METHODS 
A. Bone-Anchored / Electrode Device Construction 
An osseointegrated transcutaneous implanted device was 
made from Ti-6Al-4V (Fig. 1.) as described by Pendegrass et 
al. [13]. A straight 2 mm hole was drilled from the top surface 
of the device, exiting immediately within the soft tissues 
above the region of the implant associated with 
osseointegration, this eliminated the need for an additional 
hole in the tibial cortex. A schematic of the device is shown in 
fig. 2. 
A bipolar epimysial electrode (Ardiem Medical Inc., PA, 
USA) was chosen. The electrode consisted of 2 circular Pt/Ir 
disks (10.64 mm²), with an interelectrode distance of 10.0mm, 
on a polyester reinforced silicone backing. The lead was 316 
SS, 2-core coiled cable with fluoropolymer insulation 
encapsulated in silicone. 
The cable for the epimysial electrode was passed through 
the implant and the flying leads were crimped to a 2-pin 
socket (LEMO UK Ltd, Worthing, U.K). The socket was held 
in place in a Ti-6Al-4V sleeve press fitted over the top of the 
device. The socket and sleeve were held in place using epoxy 
resin. The cable was secured in the 2 mm hole using medical 
grade silicone elastomer (NuSil Med3-4013, NuSil 
Technology LLC, CA, USA). The silicone was degassed 
under vacuum, injected using a syringe, and cured for 24 
hours at 50°C. Care was taken to ensure no uncured silicone 
leaked onto the HA coated flange or tapered stem. The implant 
 
Fig. 1.  Bone-anchored device with epimysial electrode (1). Electrode cable 
(2) is passed through a bore-hole immediately under the flange (3), through 




Fig. 2. Schematic of the device showing central bore hole in the bone-
anchored device exiting just underneath the flange. The wire runs between 
the bone and overlying soft tissue to the epimysial electrode, which is 
sutured onto the muscle. 
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was sterilized using ethyl oxide gas. 
 
B. Surgical Technique 
One female sheep (Mule) was used for this study. All 
animal procedures were carried out in accordance with the 
Home Office Animals (Scientific Procedures) Act 1986. 
Under general anesthesia, an incision was made over the left 
tibia, 10cm inferior to the knee joint and dissection made 
down to the bone (Fig. 3.). Soft tissue was stripped off the 
tibia, both cortices were drilled and reamed and the implant 
press fitted into the hole (trans-tibial insertion), allowing 2mm 
between the flange and the underlying bone to accommodate 
the electrode wire. 
A separate incision was made overlying the lateral 
compartment muscles of the left leg. M. peronius tertius was 
identified. A subcutaneous pocket was made under the 
intervening skin between the 2 incisions through which the 
electrode was passed. The electrode was secured into position 
on the muscle using 4-0 Prolene (non-absorbable) suture. The 
wounds were washed with saline and closed tension-free in 
layers with Vicryl (absorbable) suture (Ethicon Inc., NJ, 
USA). Mepitel (Mölnlycke Health Care Limited, 
Bedfordshire, UK), sterile gauze and a bandage were used as a 
post-operative dressing. The position of the implant was 
confirmed by plain radiographs (fig. 4.). 
Antibiotics were given for 3 days post-operatively and 
fentanyl patches for one week. The animal was individually 
housed and the first EMG signals were obtained 24 hours 
post-operatively. 
 
C. EMG Recording 
On a weekly basis for 12 weeks, the animal underwent 
treadmill walking at 2km/h and signals captured using 
electromyogram (EMG) recording equipment (MP150 and 
EMG100, AcqKnowledge software, BIOPAC Systems, Inc., 
CA, USA) (Fig. 5.). EMG signals were recorded (at 500x gain, 
1000 samples per second (sps), 100 Hz to 500 Hz band-pass). 
The electrode was accessed by attaching the lead from a 
recording device to the external part of the implant (fig. 1(5).) 
using a plug and socket interface. 
Signals from overlying surface electrodes were used for 
comparison on week 2. The skin was shaved and cleaned with 
alcohol and allowed to dry. Surface electrodes (Vermed Inc., 
VT, USA) were placed on the skin directly overlying M. 
peronius tertius at an inter-electrode distance of 20mm. A 
reference electrode was placed on a bony prominence over the 
ankle.  
The absolute values were taken prior to signal analysis. 
AcqKnowledge software Mean Power was calculated over 
0.25 second epochs in a manually selected 4-second section (3 
or 4 gait cycles). Epochs with greater than mean average 
Power were considered signal, all other epochs were 
considered noise. Signal to noise ratio (SNR) was calculated 
as the ratio between the average absolute signal EMG and the 
average absolute noise EMG. 
The device eventually failed at week 12, producing 
recordings with no clearly distinguishable EMG signals. 
Device failure was due to build up of debris inside the external 
socket connector (fig. 1(5)), effectively acting as an electrical 
insulator between plug and socket. 
 
 
Fig. 3.  Bone-anchored device inserted into tibia (top left). Separate incision 
made over M. peroneus tertius (top right), the electrode passed under the 
intervening skin bridge and sutured onto the muscle (bottom left).  Wounds 
are closed in layers (bottom right). 
  
 
Fig. 4.  Plain radiographs of the device taken post-operatively. Lateral view 
(left) showing gap between flange and bone to accommodate wire (arrow), 





Fig. 5.  Typical epimysial EMG recording obtained during treadmill walking. 
3 distinct EMGs can be seen. Timeline on x-axis in seconds (large divisions).  
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D. Impedence Spectroscopy 
 In vitro impedance measurements were made using the 
EVAL-AD5934EBZ (Analog Devices, MA, USA) using the 
potentiostatic method [14].  
The standard frequency range for the impedance monitor 
was 10³ Hz to 105 Hz and the standard impedance range was 
500 Ω > Z > 1MΩ. The impedance converter system was 
calibrated using a 100kΩ (1%) resistor before each 
measurement. 
Impedance of pre-implanted and explanted epimysial 
electrodes were measured in 0.9% saline (physiological saline) 
at 1kHz to 77kHz, 0.4 Vp-p. The explanted electrode 
impedance was measured with 3 mm of surrounding tissue. 
 
E.  Histological Evaluation 
After 12 weeks the animal was sacrificed and the implant 
removed with the electrode and a cuff of underlying muscle. 
Specimens were fixed in 10% formalin, dehydrated in an 
ascending alcohol series, defatted in chloroform, and 
embedded in LR White Resin (London Resin Company 
Limited, London, UK). Sections were cut, ground and 
polished to a thickness of 100 µm and were then stained with 
toluidine blue. Histo-morphological assessment was carried 
out using an Olympus BH2 microscope (Olympus Optical 
Company Ltd, Tokyo, Japan), linked to Zeiss KS300 3.0 
image-analysis software (Imaging Associates, Thame, UK). 
 
III. RESULTS 
A. Gross morphology 
At 12 weeks the implant-skin interface was stable, showing 
no gross signs of infection or discharge (fig. 6.). A layer of 
fibrous tissue formed a capsule around the electrode and the 
electrode wire. There was no evidence of gross inflammation 
and the surrounding muscle appeared normal. The external 
socket connector showed heavy accumulation of debris within 
the electrical contact area effectively acting as an electrical 
insulator. 
 
B. Histological findings 
The silicone layer of the electrode was lost during grinding 
and polishing, leaving a distinct line at the interface with the 
underlying capsule. At 12 weeks the electrode interface 
showed encapsulation of fibrous tissue. The fibrous capsule 
was 250µm at its thickest. This consisted of parallel collagen 
fibres interspersed with fibroblasts. A well-demarcated layer 
of fibroblasts was seen at the interface with the electrode. 
Histological evaluation at the interface between the stem of 
the implant and the bone showed bone formation consistent 
with osseointegration. Epidermal and dermal attachment to the 
implant surface confirmed a stable soft-tissue-implant seal 
(fig. 7.). 
  
C. EMG results 
SNR tended to increase for the first 11 weeks of testing, 
from an initial value of 4.4 to a maximum of 6.5 in week 8 
(Fig. 8.). The SNR was greater for epimysial versus surface 
electrodes (5.1 and 1.6 respectively).  
Signal quality deteriorated rapidly after 11 weeks and 
muscle activations became difficult to identify visually due to 
excessive noise. The 1kHz epimysial electrode impedance 
increased from 1.6kΩ pre-implantation to 2.3kΩ explanted. 
 
IV. DISCUSSION 
This study is the first to combine EMG signal acquisition 
 
Fig. 7. A - Backscatter scanning electron micrograph of the bone-
anchored device. B - Arrows show ‘osseointegration’ with the HA coating 
(H) plasma sprayed onto the stem (S). C - Section through the skin-implant 
interface showing the keratinized epithelium (E) integrating with the stem (S) 
and adjacent HA coating (H). 
.  
! 
Fig. 8.  SNR for epimysial electrode over the implantation period. Signal 
quality after the last reading shown deteriorated significantly due to build up 
of debris in the external socket compromising electric conduction.   Fig. 6.  Implant-skin interface at 12 weeks showing a stable skin interface.  
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through a bone-anchored device from a cognisant, walking 
animal over 12-weeks. Throughout this period, the quality of 
the signals was maintained and the device eventually failed. 
This was due to build up of debris inside the exposed external 
socket connector (fig. 1(5)), a result of the sheep being housed 
in a barn environment. This was not due to soft-tissue issues. 
Fitting the external socket with a protective dust cap could 
have prevented this. The conduit and internal part of the 
electrode remained functional as demonstrated by impedance 
spectroscopy. 
Implantable muscle electrodes have advantages over skin-
surface electrodes: small, discreet or deep muscles responsible 
for specific actions can be individually targeted; electrode 
location is consistent and permanent; there are no effects of 
perspiration or patient weight-changes; and the impact of skin 
deformation is eliminated. Where TMR is indicated, the 
surgeon performing nerve coaptation can implant the 
electrodes during the same procedure, optimising accuracy of 
placement and eliminating the need to wear a waistcoat with a 
multitude of skin-surface electrodes [5]. By combining these 
advantages with the benefits of using bone-anchored 
prostheses, patients will have simpler, more robust systems 
with a single connection for both attachment and control. 
Critical to the success of this approach is the establishment 
of a stable skin-implant interface. Traditional bone-anchored 
devices have suffered from a high rate of infection and chronic 
inflammation necessitating explantation [15], [16]. Pendegrass 
et al. [13] have demonstrated a bone-anchored device design 
with a robust skin-implant seal, which was clinically 
successful in a trans-humeral amputee [11]. A modification of 
this implant was used in our experiment. 
Since the aim of the paper was to test the ability of the 
device to transmit EMG signals over time, we did not feel that 
an amputation model and longitudinal insertion was 
warranted. For this reason we implanted the device 
transversely. However, in human application, the device will 
be implanted longitudinally into the medullary canal of the 
long bone (radius or humerus).  
In this model, we passed the electrode wire underneath the 
flange, removing the need for an additional hole in the cortex 
to transmit the wire, as described in a previous study [12]. As 
HA is osseoconductive, bone can grow along the surface of 
the stem right up to the flange area (fig. 7. A), a phenomenon 
known as bony bridging. However this did not affect 
transmission of signals. Furthermore, since the wire is encased 
in polymeric material, it does not osseointegrate. This setup 
simplifies the operative procedure and reduces the risk of wire 
damage when passing through an additional hole in the cortex 
(or potential damage during the bone-healing process).  
Hard-wired constructs allow an increase in the number of 
channels without a disproportionate increase in the complexity 
of the implanted components. In contrast, signal telemetry 
requires ever increasing bandwidth, and therefore power 
consumption, to cope with high channel numbers and data 
rates. Crucially this system allows for a multi-channel setup 
providing the user with highly intuitive control of prosthesis. 
Pitkin [12] reported on the use of a titanium pylon bone-
anchored device as a conduit to take signals from internal 
microelectrodes through the skin barrier in a rabbit. The pylon 
was inserted into the tibia, and an additional hole was bored, 
through which wires exited the medullary canal. A single 
reading was obtained with the animal sedated by eliciting the 
‘righting reflex’. We recorded ‘physiological’ signals, by 
walking the animal on a treadmill, during a 12-week period. 
By passing the wire under the flange instead of the distal-most 
part of the bone-anchored device, we eliminated the need for 
an additional hole in the tibia.  
The use of hard-wired bone-anchored devices is not limited 
to EMG signals. A sensory feedback loop could be setup 
transducing electrical impulses from pressure sensors in the 
prosthesis to sensory nerves in the residual stump. A similar 
setup can also be used for peripheral or central nervous system 
recordings and the recording of other biosignals. Direct 
recording of electroneurography (ENG) signals from 
peripheral motor nerves using implanted nerve electrodes can 
potentially yield all the signals required to control a prosthetic 
limb [1], [17]. The bandwidth requirements for ENG signals 
are greater than for EMG signals, and hard-wired transmission 
of these signals out of the body ensures fast data transfer 
without a drop in bandwidth associated with wireless 
telemetry. Accurate and reliable long-term ENG signal capture 
coupled with a bone-anchored device may provide the ideal 
solution for attachment and control of prosthetic limbs in the 
future. 
An ovine model was chosen due to previous experience 
with bone-anchored devices in this model [13]. However, skin 
differences may make comparisons between epimysial and 
skin-surface EMG inapplicable to human patients. 
Additionally we have not evaluated potential signal 
interference from neighbouring muscles. To test this fully, 
selective intraoperative muscle stimulation can be used to 
measure cross-talk. To minimise cross-talk, the electrode was 
placed along the longitudinal axis of the muscle, with adjacent 
muscles (tibialis anterior and gastrocnemius) at least 20mm 
from the center of the discs. 
In addition to implantable electrodes, pattern recognition 
could provide a solution to simultaneous movements of the 
prosthesis, using several surface electrodes placed on the 
amputation stump to detect MES in the residual stump. 
Although studies have shown no significant difference in 
classification accuracy of pattern recognition-based 
myoelectric controllers utilising surface vs. intramuscular 
electrodes [4,18], such experiments were carried out in the 
ideal laboratory environment, where problems related to the 
long-term consistency of signals were not fully investigated. 
These include signal changes due to skin impedance 
secondary to sweating, the need for repeated placements of 
electrodes, accuracy and consistency of electrode placement, 
electrode lift-off and motion artefact. These problems are 
addressed with implantable electrodes. Thus in systems 
employing direct control and pattern recognition, implantable 
electrodes may confer an advantage over surface electrodes. 
Several design modifications are needed to translate this 
proof of concept into a human design, and work is underway 
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to address these. The device will be inserted longitudinally 
into the medullary cavity of the radius/humerus instead of 
transcortically as described in this experiment. Additionally 
the seal around the borehole in the device will be a hermetic 
feed-through, to ensure a stable interface between the external 
and internal environments. The electrode wire will exit the 
device under the flange as described in this experiment, 
avoiding the need for an additional hole to be made in the 
diaphysis of the bone. Small alterations to the hard-wired 
system, such as the introduction of multiplexing, tripolar 
electrodes and electrode-site preamplification can be used to 
reduce the complexity of the implant-prosthesis connection, 
increase noise rejection, and reduce the noise resulting from 
cable motion respectively. Electrodes can be connected intra-
operatively to the multiplexer using a reconnectable multiway 
implantable connector, which was shown to provide a stable 
long-term connection in human applications [18]. This setup 
allows individual replacement of electrodes/multiplexer 
should a fault arise in the future, without the need to replace 
the entire device. 
The mechanical coupling between the device and the 
external prosthesis has been used by the co-author in an upper 
limb amputee fitted with a bone-anchored device, which will 
be applied to the final design. A fail-safe mechanism, which is 
designed to shear in half if the load applied to the prosthesis 
exceeds a specified limit, is inserted between the external part 
of the device and the external prosthesis. This also protects the 
bone from fracturing in the event of a fall onto the 
reconstructed arm [11].  
A long-term, stable electrical coupling is currently under 
development with a similar failsafe device to protect the 
coupling in case of mechanical overloading. 
This technology could also be applied to lower limb 
prostheses for control of ankle in below knee amputees with 
adequate residual leg muscles (tibialis anterior and 
gastrocnemius, which dorsiflex and plantarflex the ankle, 
respectively). However, the limited functional range of 
movement of the lower limb compared with the upper limb, 
and the availability of quality lower limb prostheses means the 
demand for an implantable electrode system is low. 
 
V. CONCLUSION 
1. This study was the first to combine EMG signal acquisition 
through a bone-anchored device from a cognisant, walking 
animal over a 12-week period. 
2. This technology forms the basis of a complete solution for 
upper limb amputees – both attachment and control. 
3. Addition of a multiplexer allows a multichannel design, 
providing intuitive, physiological control of the end device.  
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